---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-027093"
form_type: "8-K"
ticker: "AIMD"
cik: "0001014763"
company_name: "Ainos, Inc."
filed_at: "2024-07-12T23:59:59+00:00"
generated_at: "2026-05-31T20:54:23.079557+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Ainos extends patent license with TCNT for three months at $95k/month

## Summary
- Second Addendum extends non-exclusive patent use for VOC/POCT tech from July to Sept 2024.
- Monthly fee of US$95,000 plus 5% sales tax for the three-month extension.
- Co-development fee of NT$5 million (≈USD$161,000) paid for five-year period starting 2024.
- TCNT holds ~39% voting power of Ainos via a Cayman entity; related party transaction.
- Scope includes VOC diagnostics, AI Nose, POCT, VELDONA drug processing, and more.

## SEC filing metadata
- accession: 0001493152-24-027093
- form_type: 8-K
- ticker: AIMD
- cik: 0001014763
- company_name: Ainos, Inc.
- filed_at: 2024-07-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1014763/000149315224027093/0001493152-24-027093-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1014763/000149315224027093/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-027093
- JSON: https://secwatch.observer/filing/0001493152-24-027093.json
- Plain text: https://secwatch.observer/filing/0001493152-24-027093.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.